Tokio Marine Asset Management Co. Ltd. Raises Holdings in Humana Inc. (NYSE:HUM)

Tokio Marine Asset Management Co. Ltd. lifted its position in Humana Inc. (NYSE:HUM) by 4.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,731 shares of the insurance provider’s stock after buying an additional 111 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Humana were worth $1,250,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Rakuten Securities Inc. bought a new stake in Humana during the fourth quarter valued at about $25,000. Gradient Investments LLC boosted its position in shares of Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after buying an additional 40 shares during the period. Cetera Trust Company N.A purchased a new stake in shares of Humana in the fourth quarter valued at approximately $28,000. Nvwm LLC boosted its holdings in shares of Humana by 41.0% in the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after purchasing an additional 25 shares during the period. Finally, Turtle Creek Wealth Advisors LLC bought a new position in Humana in the fourth quarter worth approximately $55,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Humana

In related news, Director Jorge S. Mesquita acquired 545 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was bought at an average cost of $367.09 per share, with a total value of $200,064.05. Following the acquisition, the director now directly owns 2,578 shares in the company, valued at $946,358.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.32% of the company’s stock.

Humana Trading Down 1.4 %

Shares of HUM stock traded down $4.41 during mid-day trading on Friday, reaching $307.00. The company’s stock had a trading volume of 109,332 shares, compared to its average volume of 1,980,397. The company’s 50 day simple moving average is $328.56 and its 200-day simple moving average is $395.71. Humana Inc. has a 12-month low of $299.23 and a 12-month high of $541.21. The company has a quick ratio of 1.59, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $37.04 billion, a PE ratio of 19.39, a price-to-earnings-growth ratio of 1.85 and a beta of 0.45.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The business had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same quarter last year, the firm posted $9.38 EPS. On average, research analysts predict that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s payout ratio is 22.04%.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. The Goldman Sachs Group reduced their price objective on shares of Humana from $450.00 to $385.00 and set a “buy” rating for the company in a research note on Wednesday, April 3rd. Barclays lowered their price target on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 2nd. Jefferies Financial Group lowered their target price on shares of Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research note on Monday. Argus lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, March 13th. Finally, UBS Group decreased their price target on shares of Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research note on Thursday. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $433.74.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.